摘要
目的研究黄芪多糖(astragalus polysaccharide,APS)对肾阳虚型糖尿病大鼠肾脏TGF-β_1表达的影响。方法用SD雄性大鼠制作肾阳虚糖尿病大鼠模型;将模型鼠随机分为3组:对照组,苯那普利治疗组,黄芪多糖治疗组。于实验第8周时统一处死各组老鼠,测定大鼠肾脏重量/体重、血糖、血脂;用RT-PCR检测各组大鼠肾组织TGF-β_1 mRNA表达。结果APS可明显降低肾脏重量/体重、血糖、血脂,并能使大鼠肾组织TGF-β_1 mRNA表达减少。结论APS可能通过改善大鼠血糖、血脂降低TGF-β_1 mRNA的表达,进而阻滞糖尿病肾病的发生和发展;APS有可能成为临床治疗肾阳虚型糖尿病的有效药物。
Objective To investigate the effect of APS (astragalus polysaccharides) inhibiting TGF-β1 (transforming growth factor-β1) in the renal tissue of diabetic rats with deficiency Of kidney-Yang syndrome. Methods Male SD rats were divided into 3 groups: the diabetic nephropathy group, benazepril group, APS group. At the end of 8th week, the kidneys were taken out from all the rats to detect the mRNA expression of TGF-β1 by RT-PCR (reverse transcript polymerase chain reaction).The renal weight/body ratio was measured, as well as the change of blood sugar(BS) and blood fat. Results Compared with benazepril, APS significantly inhibited the expression of TGF-β1 mRNA, decreased the renal weight/body ratio, BS and blood fat. Conclusion TGF-β1 is activated in the diabetic kidneys. APS can decrease the mRNA expression ofTGF-β1 in diabetic kidneys and delay the development of DN.
出处
《医学新知》
CAS
2008年第4期213-216,共4页
New Medicine
基金
湖北省自然科学基金(2004ABA160)
关键词
糖尿病
肾阳虚
黄芪多糖
TGF-β1
diabetes mellitus
deficiency ofkidney-yang syndrome
astragalus polysaccharide
TGF-β1